Estalis Sequi

Riik: Uus-Meremaa

keel: inglise

Allikas: Medsafe (Medicines Safety Authority)

Toimeaine:

Estradiol 4.33mg equivalent to 50 µg/24h oestradiol; Estradiol hemihydrate 0.62mg equivalent to oestradiol 50 µg/24 hours;  ; Norethisterone acetate 2.7mg equivalent to norethisterone acetate 140 µg/24 hours;  

Saadav alates:

Novartis New Zealand Ltd

INN (Rahvusvaheline Nimetus):

Estradiol 4.33 mg (equivalent to 50 µg/24h oestradiol)

Annus:

50 + 50/140

Ravimvorm:

Transdermal patch

Koostis:

Active: Estradiol 4.33mg equivalent to 50 µg/24h oestradiol Excipient: 1,3-Butylene glycol Acrylic adhesive Bentonite Dipropylene glycol Ethylenevinylacetate copolymer Lecithin Liquid paraffin Oleic acid Polyisobutylene Synthetic adhesive Active: Estradiol hemihydrate 0.62mg equivalent to oestradiol 50 µg/24 hours   Norethisterone acetate 2.7mg equivalent to norethisterone acetate 140 µg/24 hours   Excipient: Acrylic adhesive Dipropylene glycol Oleic acid Povidone Silicone adhesive

Ühikuid pakis:

Sachet, aluminium foil, laminate paper/PE/Al/PE, 8 patches

Klass:

Prescription

Retsepti tüüp:

Prescription

Valmistatud:

NV Organon

Toote kokkuvõte:

Package - Contents - Shelf Life: Sachet, aluminium foil, laminate paper/PE/Al/PE - 8 patches - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) 6 months opened stored at or below 25°C

Loa andmise kuupäev:

2002-07-12